Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-02-20
1990-08-28
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514428, 548541, 548556, C07D20712, A61K 3140
Patent
active
049526006
ABSTRACT:
This disclosure describes novel 3 or 4 substituted oxotremorine derivatives having polar substituted oxygen or sulfur groups. The compounds have cholinergic activity. Also disclosed are methods for treating diseases of the central nervous system in mammals employing the compounds, pharmaceutical preparations containing the compounds and processes for the production of the compounds.
REFERENCES:
patent: 4243672 (1981-01-01), Barnish et al.
patent: 4536500 (1985-08-01), Bourgery et al.
patent: 4847284 (1989-07-01), Schwartz et al.
Brabander Herbert J.
Kramss Richard H.
Trybulski Eugene J.
American Cyanamid Company
Dow Kenneth J.
Springer David B.
LandOfFree
3- or 4-substituted oxotremorine derivatives and a method of tre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3- or 4-substituted oxotremorine derivatives and a method of tre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3- or 4-substituted oxotremorine derivatives and a method of tre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1590195